Equities

Globus Medical Inc

Globus Medical Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)68.05
  • Today's Change0.13 / 0.19%
  • Shares traded693.17k
  • 1 Year change+14.29%
  • Beta1.1503
Data delayed at least 15 minutes, as of Jul 03 2024 00:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. It includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.

  • Revenue in USD (TTM)1.90bn
  • Net income in USD66.63m
  • Incorporated2003
  • Employees5.00k
  • Location
    Globus Medical Inc2560 General Armistead AveAUDUBON 19403-5214United StatesUSA
  • Phone+1 (610) 930-1800
  • Fax+1 (302) 636-5454
  • Websitehttps://www.globusmedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Merit Medical Systems Inc1.28bn101.95m4.98bn6.95k49.104.0125.523.881.741.7421.9621.350.642.327.32184,648.805.082.455.652.7746.5444.507.943.914.3811.610.39220.009.247.3326.7015.86-11.16--
DENTSPLY SIRONA Inc3.94bn-95.00m5.11bn15.00k--1.5720.211.30-0.4468-0.446818.6915.690.53262.946.02262,666.70-1.24-1.14-1.52-1.3252.6153.65-2.34-2.510.96923.270.3908--1.10-0.107186.11---4.549.86
Lantheus Holdings Inc1.37bn460.53m5.55bn834.0012.215.8610.634.066.556.5519.4213.640.85878.784.711,637,434.0028.966.6934.547.7364.0253.9033.729.024.55--0.37330.0038.6530.441,063.8651.8135.48--
Stevanato Group SpA1.16bn146.22m5.65bn5.64k33.97--29.664.860.55140.55144.38--------206,444.90--------30.81--12.57----32.91----10.34--1.95------
Glaukos Corp326.43m-140.87m5.91bn907.00--12.99--18.12-2.88-2.886.689.040.34261.727.74359,905.20-14.78-8.73-15.91-9.3576.1874.77-43.16-28.694.68-38.380.4395--11.2611.66-35.75--14.44--
Masimo Corp1.98bn79.10m6.19bn3.80k79.504.5335.273.131.461.4636.5425.710.65072.015.24519,973.702.608.653.1710.3148.6157.304.0012.031.313.610.39090.000.604219.00-43.21-15.9631.06--
Penumbra Inc1.10bn93.39m6.86bn4.20k74.505.7056.466.262.382.3827.9031.050.73661.035.49260,899.806.282.326.982.6165.0463.908.523.173.51--0.02070.0024.9518.934,643.1668.609.64--
Repligen Corp607.45m14.84m6.89bn1.78k488.553.4981.5811.340.25240.252410.7435.290.22551.434.87340,689.800.5514.380.61795.0347.7355.432.4415.915.24--0.22840.00-20.3126.91-77.6420.1324.99--
Bio Rad Laboratories Inc2.61bn-322.37m7.63bn8.03k--0.8319--2.93-10.36-10.3689.91317.320.19831.585.52324,438.10-2.459.08-2.569.6053.5355.55-12.3741.974.890.44960.1170.00-4.673.1382.43--3.83--
Henry Schein, Inc.12.45bn388.00m8.34bn25.00k22.012.3212.590.66962.962.9695.1128.021.334.748.00498,040.004.206.096.8010.4431.3830.043.164.401.028.260.32070.00-2.445.55-22.68-0.145621.27--
Globus Medical Inc1.90bn66.63m9.17bn5.00k107.472.3436.764.830.6320.63215.4829.040.53531.265.01379,690.801.886.902.177.4562.1471.733.5114.051.29--0.09770.0053.3417.08-35.39-4.725.57--
Bruker Corp3.00bn401.60m9.43bn9.71k22.766.4017.933.142.742.7420.449.740.72571.535.78309,148.009.718.3813.4511.4050.4349.8513.3811.390.8889156.500.48729.8117.149.3644.0318.9116.794.56
Teleflex Inc3.00bn296.02m9.96bn14.50k33.802.2118.303.326.266.2363.4195.610.4172.146.99206,993.504.115.864.476.4255.7054.439.8614.621.417.670.280815.846.573.97-1.4712.732.510.00
Revvity Inc2.73bn183.35m12.71bn11.50k69.751.6220.704.661.481.2121.9663.540.19422.874.64237,011.001.314.761.465.3955.5257.196.7315.341.926.110.33076.52-16.95-0.1982-64.99-5.28-2.690.00
Data as of Jul 03 2024. Currency figures normalised to Globus Medical Inc's reporting currency: US Dollar USD

Institutional shareholders

42.10%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 202410.79m9.58%
BlackRock Fund Advisorsas of 31 Mar 202410.09m8.96%
Janus Henderson Investors US LLCas of 31 Mar 20247.60m6.75%
SSgA Funds Management, Inc.as of 31 Mar 20243.58m3.18%
Wellington Management Co. LLPas of 31 Mar 20243.25m2.89%
Champlain Investment Partners LLCas of 31 Mar 20242.50m2.22%
Camber Capital Management LPas of 31 Mar 20242.50m2.22%
Burgundy Asset Management Ltd.as of 31 Mar 20242.48m2.20%
Hawk Ridge Capital Management LPas of 31 Mar 20242.37m2.10%
William Blair Investment Management LLCas of 31 Mar 20242.25m2.00%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.